Skip to main content

Advertisement

Log in

Diabetic cardiomyopathy

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Diabetes mellitus is well recognized as a potent and prevalent risk factor for accelerated atherosclerosis and ischemic heart disease. However, there is also evidence of cardiac dysfunction in diabetes in the absence of coronary atherosclerosis, termed diabetic cardiomyopathy. Changes in ventricular structure and left ventricular systolic and diastolic dysfunction have all been noted even in patients with well-controlled diabetes and without overt macrovascular complications. Insulin resistance, hyperglycemia, and increased free fatty acid metabolism promote coronary microvascular disease, sympathetic nervous system dysfunction, and ventricular remodeling, and may contribute to the altered cardiac phenotype seen in diabetes. In addition to standard therapy (angiotensin-converting enzyme inhibitors and β-blockers), diabetic patients with left ventricular dysfunction are likely to benefit from targeted therapies to reduce insulin resistance and modulate substrate use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002, 287:2570–2581.

    Article  PubMed  CAS  Google Scholar 

  2. Ingelsson E, Arnlov J, Sundstrom J, et al.: Novel metabolic risk factors for heart failure. J Am Coll Cardiol 2005, 46:2054–2060.

    Article  PubMed  CAS  Google Scholar 

  3. Das SR, Drazner MH, Yancy CW, et al.: Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention trial. Am Heart J 2004, 148:883–888.

    Article  PubMed  Google Scholar 

  4. Kannel WB, Hjortland M, Castelli WP: Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974, 34:29–34.

    Article  PubMed  CAS  Google Scholar 

  5. Gottdiener JS, Arnold AM, Aurigemma GP, et al.: Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000, 35:1628–1637.

    Article  PubMed  CAS  Google Scholar 

  6. Bertoni AG, Tsai A, Kasper EK, Brancati FL: Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. Diabetes Care 2003, 26:2791–2795.

    Article  PubMed  Google Scholar 

  7. Rubler S, Dlugash J, Yuceoglu YZ, et al.: New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972, 30:595–602.

    Article  PubMed  CAS  Google Scholar 

  8. Taegtmeyer H, McNulty P, Young ME: Adaptation and maladaptation of the heart in diabetes. Part I: general concepts. Circulation 2002, 105:1727–1733.

    Article  PubMed  CAS  Google Scholar 

  9. Young ME, McNulty P, Taegtmeyer H: Adaptation and maladaptation of the heart in diabetes. Part II: potential mechanisms. Circulation 2002, 105:1861–1870.

    Article  PubMed  CAS  Google Scholar 

  10. Ho KK, Pinsky JL, Kannel WB, Levy D: The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993, 22:6A–13A.

    Article  PubMed  CAS  Google Scholar 

  11. Davis BR, Piller LB, Cutler JA, et al.: Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation 2006, 113:2201–2210.

    Article  PubMed  CAS  Google Scholar 

  12. Galderisi M: Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography. J Am Coll Cardiol 2006, 48:1548–1551.

    Article  PubMed  Google Scholar 

  13. Rutter MK, Parise H, Benjamin EJ, et al.: Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 2003, 107:448–454.

    Article  PubMed  CAS  Google Scholar 

  14. Ilercil A, Devereux RB, Roman MJ, et al.: Associations of insulin levels with left ventricular structure and function in American Indians: the strong heart study. Diabetes 2002, 51:1543–1547.

    Article  PubMed  CAS  Google Scholar 

  15. Bella JN, Devereux RB, Roman MJ, et al.: Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study). Am J Cardiol 2001, 87:1260–1265.

    Article  PubMed  CAS  Google Scholar 

  16. Fox ER, Taylor J, Taylor H, et al.: Left ventricular geometric patterns in the Jackson cohort of the Atherosclerotic Risk in Communities (ARIC) Study: clinical correlates and influences on systolic and diastolic dysfunction. Am Heart J 2007, 153:238–244.

    Article  PubMed  Google Scholar 

  17. Bursi F, Weston SA, Redfield MM, et al.: Systolic and diastolic heart failure in the community. JAMA 2006, 296:2209–2216.

    Article  PubMed  CAS  Google Scholar 

  18. Liu JE, Palmieri V, Roman MJ, et al.: The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol 2001, 37:1943–1949.

    Article  PubMed  CAS  Google Scholar 

  19. Adal E, Koyuncu G, Aydin A, et al.: Asymptomatic cardiomyopathy in children and adolescents with type 1 diabetes mellitus: association of echocardiographic indicators with duration of diabetes mellitus and metabolic parameters. J Pediatr Endocrinol Metab 2006, 19:713–726.

    PubMed  Google Scholar 

  20. Grandi AM, Piantanida E, Franzetti I, et al.: Effect of glycemic control on left ventricular diastolic function in type 1 diabetes mellitus. Am J Cardiol 2006, 97:71–76.

    Article  PubMed  CAS  Google Scholar 

  21. Diamant M, Lamb HJ, Groeneveld Y, et al.: Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 2003, 42:328–335.

    Article  PubMed  CAS  Google Scholar 

  22. Bajraktari G, Koltai MS, Ademaj F, et al.: Relationship between insulin resistance and left ventricular diastolic dysfunction in patients with impaired glucose tolerance and type 2 diabetes. Int J Cardiol 2006, 110:206–211.

    Article  PubMed  Google Scholar 

  23. Vinereanu D, Nicolaides E, Tweddel AC, et al.: Subclinical left ventricular dysfunction in asymptomatic patients with Type II diabetes mellitus, related to serum lipids and glycated haemoglobin. Clin Sci (Lond) 2003, 105:591–599.

    CAS  Google Scholar 

  24. Sasso FC, Carbonara O, Cozzolino D, et al.: Effects of insulin-glucose infusion on left ventricular function at rest and during dynamic exercise in healthy subjects and noninsulin dependent diabetic patients: a radionuclide ventriculographic study. J Am Coll Cardiol 2000, 36:219–226.

    Article  PubMed  CAS  Google Scholar 

  25. Di Cori A, Di Bello V, Miccoli R, et al.: Left ventricular function in normotensive young adults with well-controlled type 1 diabetes mellitus. Am J Cardiol 2007, 99:84–90.

    Article  PubMed  Google Scholar 

  26. Watts GF, Marwick TH: Ventricular dysfunction in early diabetic heart disease: detection, mechanisms and significance. Clin Sci (Lond) 2003, 105:537–540.

    CAS  Google Scholar 

  27. Held C, Gerstein HC, Yusuf S, et al.: Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk. Circulation 2007, 115:1371–1375.

    Article  PubMed  CAS  Google Scholar 

  28. Suskin N, McKelvie RS, Burns RJ, et al.: Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J 2000, 21:1368–1375.

    Article  PubMed  CAS  Google Scholar 

  29. McGavock JM, Victor RG, Unger RH, Szczepaniak LS: Adiposity of the heart, revisited. Ann Intern Med 2006, 144:517–524.

    PubMed  CAS  Google Scholar 

  30. Zethelius B, Byberg L, Hales CN, et al.: Proinsulin and acute insulin response independently predict Type 2 diabetes mellitus in men—report from 27 years of follow-up study. Diabetologia 2003, 46:20–26.

    PubMed  CAS  Google Scholar 

  31. Shah A, Shannon RP: Insulin resistance in dilated cardiomyopathy. Rev Cardiovasc Med 2003, 4(Suppl 6):S50–S57.

    PubMed  Google Scholar 

  32. Dutka DP, Pitt M, Pagano D, et al.: Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease. J Am Coll Cardiol 2006, 48:2225–2231.

    Article  PubMed  CAS  Google Scholar 

  33. An D, Rodrigues B: Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 2006, 291:H1489–H1506.

    Article  PubMed  CAS  Google Scholar 

  34. Herrero P, Peterson LR, McGill JB, et al.: Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus. J Am Coll Cardiol 2006, 47:598–604.

    Article  PubMed  CAS  Google Scholar 

  35. Pop-Busui R, Kirkwood I, Schmid H, et al.: Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction. J Am Coll Cardiol 2004, 44:2368–2374.

    Article  PubMed  CAS  Google Scholar 

  36. Prior JO, Quinones MJ, Hernandez-Pampaloni M, et al.: Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation 2005, 111:2291–2298.

    Article  PubMed  CAS  Google Scholar 

  37. Lautamaki R, Airaksinen KE, Seppanen M, et al.: Insulin improves myocardial blood flow in patients with type 2 diabetes and coronary artery disease. Diabetes 2006, 55:511–516.

    Article  PubMed  CAS  Google Scholar 

  38. Quinones MJ, Hernandez-Pampaloni M, Schelbert H, et al.: Coronary vasomotor abnormalities in insulin-resistant individuals. Ann Intern Med 2004, 140:700–708.

    PubMed  Google Scholar 

  39. Schindler TH, Facta AD, Prior JO, et al.: Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes. Heart 2007, 93:345–349.

    Article  PubMed  CAS  Google Scholar 

  40. Wang L, Jerosch-Herold M, Jacobs DR, Jr., et al.: Coronary risk factors and myocardial perfusion in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2006, 47:565–572.

    Article  PubMed  Google Scholar 

  41. Asbun J, Villarreal FJ: The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol 2006, 47:693–700.

    Article  PubMed  CAS  Google Scholar 

  42. Di Bello V, Talarico L, Picano E, et al.: Increased echodensity of myocardial wall in the diabetic heart: an ultrasound tissue characterization study. J Am Coll Cardiol 1995, 25:1408–1415.

    Article  PubMed  Google Scholar 

  43. Wong CY, O’Moore-Sullivan T, Leano R, et al.: Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 2004, 110:3081–3087.

    Article  PubMed  Google Scholar 

  44. Vinik AI, Ziegler D: Diabetic cardiovascular autonomic neuropathy. Circulation 2007, 115:387–397.

    Article  PubMed  Google Scholar 

  45. Manzella D, Paolisso G: Cardiac autonomic activity and type II diabetes mellitus. Clin Sci (Lond) 2005, 108:93–99.

    Article  Google Scholar 

  46. Haas SJ, Vos T, Gilbert RE, Krum H: Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials. Am Heart J 2003, 146:848–853.

    Article  PubMed  CAS  Google Scholar 

  47. Domanski M, Krause-Steinrauf H, Deedwania P, et al.: The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. J Am Coll Cardiol 2003, 42:914–922.

    Article  PubMed  Google Scholar 

  48. Shekelle PG, Rich MW, Morton SC, et al.: Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J Am Coll Cardiol 2003, 41:1529–1538.

    Article  PubMed  CAS  Google Scholar 

  49. Torp-Pedersen C, Metra M, Charlesworth A, et al.: Effects of metoprolol and carvedilol on preexisting and new on-set diabetes in patients with chronic heart failure: data from the carvedilol or metoprolol European trial (COMET). Heart 2007, 93:968–973.

    Article  PubMed  CAS  Google Scholar 

  50. Packer M, Poole-Wilson PA, Armstrong PW, et al.: Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation 1999, 100:2312–2318.

    PubMed  CAS  Google Scholar 

  51. Cohn JN, Tognoni G: A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001, 345:1667–1675.

    Article  PubMed  CAS  Google Scholar 

  52. Pfeffer MA, Swedberg K, Granger CB, et al.: Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003, 362:759–766.

    Article  PubMed  CAS  Google Scholar 

  53. Abuissa H, Jones PG, Marso SP, O’Keefe JH, Jr.: Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 2005, 46:821–826.

    Article  PubMed  CAS  Google Scholar 

  54. Sokos GG, Nikolaidis LA, Mankad S, et al.: Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure. J Card Fail 2006, 12:694–699.

    Article  PubMed  CAS  Google Scholar 

  55. Towler MC, Hardie DG: AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 2007, 100:328–341.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard P. Shannon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karnik, A.A., Fields, A.V. & Shannon, R.P. Diabetic cardiomyopathy. Current Science Inc 9, 467–473 (2007). https://doi.org/10.1007/s11906-007-0086-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-007-0086-3

Keywords

Navigation